The two-year period of 2021–2022 saw a significant increase in nominal public healthcare spending, a rise in personnel, and a series of measures aimed at reducing waiting lists.
This contribution first examined how these additional resources and policies have not translated into a proportional increase in the actual value of specialty services (inpatient and outpatient) provided.
Secondly, the study delved into the trends within the main macro-groups of services (FA-RE categories) to identify internal differences within the outpatient specialty sector: only laboratory services showed significant increases, while the areas most targeted by waitlist reduction policies paradoxically faced the most critical challenges.
These findings highlight the importance of regulatory, accessibility, clinical governance, and organizational factors,
emphasizing the need to implement models strongly based on patient-centered care.